APOE and skin cancer: Additionally, the findings suggest that the SKH-hr2 and SKH-hr2+ApoE models are particularly well suited for investigating the pathophysiology of cSCC and testing novel therapeutic interventions, making them promising tools for advancing skin cancer treatment.